Journal article
Alzheimer's & Dementia, 2024
APA
Click to copy
Duggan, M. R., Yang, Z., Cui, Y., Dark, H. E., Wen, J., Erus, G., … Walker, K. A. (2024). Proteomic analyses reveal plasma EFEMP1 and CXCL12 as biomarkers and determinants of neurodegeneration. Alzheimer's &Amp; Dementia.
Chicago/Turabian
Click to copy
Duggan, Michael R., Zhijian Yang, Yuhan Cui, H. E. Dark, Junhao Wen, G. Erus, T. Hohman, et al. “Proteomic Analyses Reveal Plasma EFEMP1 and CXCL12 as Biomarkers and Determinants of Neurodegeneration.” Alzheimer's & Dementia (2024).
MLA
Click to copy
Duggan, Michael R., et al. “Proteomic Analyses Reveal Plasma EFEMP1 and CXCL12 as Biomarkers and Determinants of Neurodegeneration.” Alzheimer's &Amp; Dementia, 2024.
BibTeX Click to copy
@article{michael2024a,
title = {Proteomic analyses reveal plasma EFEMP1 and CXCL12 as biomarkers and determinants of neurodegeneration},
year = {2024},
journal = {Alzheimer's & Dementia},
author = {Duggan, Michael R. and Yang, Zhijian and Cui, Yuhan and Dark, H. E. and Wen, Junhao and Erus, G. and Hohman, T. and Chen, Jingsha and Lewis, Alexandria and Moghekar, A. and Coresh, J. and Resnick, Susan M. and Davatzikos, C. and Walker, Keenan A.}
}
Plasma proteomic analyses of unique brain atrophy patterns may illuminate peripheral drivers of neurodegeneration and identify novel biomarkers for predicting clinically relevant outcomes.